CLDF Title
Contact Us | Bookmark
Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
  Liver News - REUTERS   Congress Calendar   Physician Resources  
Liquid biopsy spots early liver cancer in patients with HBV infection
REFILE-Stopping oral antiviral therapy in chronic hep B possible for some people
Model finds bariatric surgery cost-effective in NASH
Stopping oral antiviral therapy in chronic hep B possible for some people
Whole grains might help protect against liver cancer
View Complete News Library
View all Congresses
  Featured Abstracts          
Bridging the access gap: Medicare ineligibility in people living with chronic hepatitis B
Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses
A global meta-analysis on HIV, hepatitis C and hepatitis B among people who inject drugs - do gender differences vary by country-level indicators?
Antiviral therapy and the development of osteopenia/osteoporosis among Asians with chronic hepatitis B
Use of Ribavirin for Hepatitis C Treatment in the Modern Direct-acting Antiviral Era
Effect of Hepatitis C Treatment on Renal Function in Liver Transplant Patients
Integrating comprehensive hepatitis C virus care within a residential substance use disorder treatment program
Treating HCV Infection: It Doesn't Get Much Better Than This
Prevalence of Hepatitis C Virus Infection in US States and the District of Columbia, 2013 to 2016
The HCV care continuum: linkage to HCV care and treatment among patients at an urban health network, Philadelphia, PA
Hepatitis C in Pregnancy: A Unique Opportunity to Improve the Hepatitis C Cascade of Care
Short-Term Effects and Long-Term Cost-Effectiveness of Universal Hepatitis C Testing in Prenatal Care
The successful scale-up of direct-acting antiviral hepatitis C treatments will benefit from concerted investments in implementation science
Impact of Substance Use Disorder on the Rate of Sustained Virological Response in Veterans With Chronic Hepatitis C Treated With Direct-Acting Antivirals
Safety and efficacy of glecaprevir/pibrentasvir in patients with chronic hepatitis C genotypes 1-6 receiving opioid substitution therapy
Efficacy and Safety of Ruzasvir 60 mg and Uprifosbuvir 450 mg for 12 Weeks in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 3, 4, or 6 Infection
National Trends and Long-term Outcomes of Liver Transplant for Alcohol-Associated Liver Disease in the United States
Predisposing Conditions to Pediatric Hepatocellular Carcinoma and Association with Outcomes: Single-Center Experience
Direct-acting antiviral agents and risk of hepatocellular carcinoma: is it still a clinical dilemma?
Racial and Geographic Disparities in Hepatocellular Carcinoma Outcomes
Weighing the benefits of hepatocellular carcinoma surveillance against potential harms
Medical treatment of advanced hepatocellular carcinoma patients: the issue is not the right drug, but the right patient
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased ?-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Regorafenib: a promising treatment for hepatocellular carcinoma
Regorafenib treatment for patients with hepatocellular carcinoma who progressed on sorafenib-A cost-effectiveness analysis
Is there increased risk of hepatocellular carcinoma recurrence in liver transplant patients with direct-acting antiviral therapy?
Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review
Cabozantinib: A Review in Advanced Hepatocellular Carcinoma
Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date
Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multi-Center Study
The Psychomotor Vigilance Task: Role in the Diagnosis of Hepatic Encephalopathy and Relationship with Driving Ability
          View All Abstracts  
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
About CLDF
Mission Statement
Board of Trustees
Board of Advisors/Faculty
CLDF Sponsors & Supporters
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
Centers of
Educational Expertise
Substance Use Disorder
CLDF Follow Us
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2019 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.